Back to RARE
AQR CAPITAL MANAGEMENT LLC → RARE
AQR CAPITAL MANAGEMENT LLC RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
43
Latest value
$210K
Q2 2026
Peak value
$213.3M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $1.4M |
| Q4 2023 | $8.1M |
| Q4 2023 | $21K |
| Q1 2024 | $22K |
| Q1 2024 | $11.6M |
| Q1 2024 | $48K |
| Q2 2024 | $123 |
| Q2 2024 | $4M |
| Q2 2024 | $9K |
| Q3 2024 | $143K |
| Q3 2024 | $418K |
| Q3 2024 | $57.2M |
| Q4 2024 | $16K |
| Q4 2024 | $11.8M |
| Q1 2025 | $21K |
| Q1 2025 | $3.3M |
| Q1 2025 | $1K |
| Q2 2025 | $39K |
| Q2 2025 | $3K |
| Q2 2025 | $76K |
| Q2 2025 | $9.1M |
| Q3 2025 | $29K |
| Q3 2025 | $10K |
| Q3 2025 | $22K |
| Q3 2025 | $22.4M |
| Q4 2025 | $69 |
| Q4 2025 | $13K |
| Q4 2025 | $31.1M |
| Q4 2025 | $46 |
| Q4 2025 | $107K |
| Q4 2025 | $31K |
| Q1 2026 | $95.6M |
| Q1 2026 | $8K |
| Q1 2026 | $2K |
| Q1 2026 | $25K |
| Q1 2026 | $244K |
| Q1 2026 | $73K |
| Q2 2026 | $48K |
| Q2 2026 | $213.3M |
| Q2 2026 | $601K |
| Q2 2026 | $3K |
| Q2 2026 | $13K |
| Q2 2026 | $210K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $210K | 6.4K | — | — |
| Q2 2026 | $13K | 410 | — | — |
| Q2 2026 | $3K | 104 | — | — |
| Q2 2026 | $601K | 18.4K | — | — |
| Q2 2026 | $213.3M | 6.53M | — | — |
| Q2 2026 | $48K | 1.5K | — | — |
| Q1 2026 | $73K | 3.5K | — | — |
| Q1 2026 | $244K | 11.6K | — | — |
| Q1 2026 | $25K | 1.2K | — | — |
| Q1 2026 | $2K | 104 | — | — |
| Q1 2026 | $8K | 401 | — | — |
| Q1 2026 | $95.6M | 4.56M | — | — |
| Q4 2025 | $31K | 1.3K | — | — |
| Q4 2025 | $107K | 4.7K | — | — |
| Q4 2025 | $46 | 2 | — | — |
| Q4 2025 | $31.1M | 1.35M | — | — |
| Q4 2025 | $13K | 585 | — | — |
| Q4 2025 | $69 | 3 | — | — |
| Q3 2025 | $22.4M | 744.2K | — | — |
| Q3 2025 | $22K | 745 | — | — |
| Q3 2025 | $10K | 327 | — | — |
| Q3 2025 | $29K | 959 | — | — |
| Q2 2025 | $9.1M | 249.1K | — | — |
| Q2 2025 | $76K | 2.1K | — | — |
| Q2 2025 | $3K | 80 | — | — |
| Q2 2025 | $39K | 1.1K | — | — |
| Q1 2025 | $1K | 38 | — | — |
| Q1 2025 | $3.3M | 91.4K | — | — |
| Q1 2025 | $21K | 598 | — | — |
| Q4 2024 | $11.8M | 280.2K | — | — |
| Q4 2024 | $16K | 375 | — | — |
| Q3 2024 | $57.2M | 1.03M | — | — |
| Q3 2024 | $418K | 7.6K | — | — |
| Q3 2024 | $143K | 2.6K | — | — |
| Q2 2024 | $9K | 216 | — | — |
| Q2 2024 | $4M | 96.9K | — | — |
| Q2 2024 | $123 | 3 | — | — |
| Q1 2024 | $48K | 1.0K | — | — |
| Q1 2024 | $11.6M | 249.7K | — | — |
| Q1 2024 | $22K | 476 | — | — |
| Q4 2023 | $21K | 438 | — | — |
| Q4 2023 | $8.1M | 170.3K | — | — |
| Q1 2023 | $1.4M | 35.9K | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$219.1M
$205.6M
$205.6M
$155.5M